Tularik Inc. (TLRK) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Tularik Inc. (TLRK)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: nigel bates who wrote (218)	6/11/2002 11:08:03 AM
From: Czechsinthemail	of 598

The Sankyo agreement is clearly a positive. And the decision to prune and use their cash on the most promising projects seems like a smart move. I think strategic targeting rather than shotgunning is a healthy indication that management is steering and selecting rather than simply throwing all the pasta against the wall and hoping something sticks. With many good programs to choose from, I'm glad to see them willing to prioritize the best: Our rich pipeline affords us the luxury of selecting the most attractive opportunities upon which to focus. The T611 anti-CMV program did not seem like one of their best bets, so I'm glad to see them pull the plug. Similarly, they had already been discussing T64 as one they wanted to turn over to someone else through a partnering agreement. I also appreciate their candid, no-BS communication. Its refreshing that they let people in on what they are doing rather than simply letting the abandoned projects wither away in silence.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next